ADAM10 and glioblastoma: It has been shown that activation of the Notch pathway promotes the development of glioblastoma, and α-secretase inhibitors inhibit the growth of glioblastoma by targeting ADAM10/17 and inhibiting the activation of the Notch pathway (Floyd et al., 2012).